溶性载体家族26成员4 (SLC26A4),喘的潜在治疗标
Vineeta Guntupalli1, Rongjun Wan1,2, Liyuan Liu1
1Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA.
概括
溶液载体 (SLC) 基因,特别是SLC26A4,涉及喘病因. SLC26A4 抑制剂在治疗喘方面表现有前途,但需要进一步研究才能找到有效的治疗方法.
科学领域:
- 分子生物学分子生物学
- 呼吸系统医学 呼吸系统医学
- 遗传学 是一个遗传学.
背景情况:
- 喘涉及复杂的机制,具有挑战性的治疗开发.
- 溶液载体 (SLC) 基因编码了对生理过程和各种疾病至关重要的膜载体.
- 编码林的SLC26A4参与阳离子运输,并与德综合征有关.
研究的目的:
- 审查对SLC基因家族功能的见解,重点关注SLC26A4在疾病中的作用.
- 探索SLC26A4在肺部疾病,特别是喘中的作用.
- 为了总结潜在的SLC26A4抑制剂用于疾病治疗.
主要方法:
- 关于SLC基因家族功能和疾病关联的文献综述.
- 专注于SLC26A4的表达,触发因素,以及喘病变中的作用.
- 已识别的SLC26A4抑制剂及其治疗潜力的摘要.
主要成果:
- 增加的SLC26A4表达与喘症状如炎症和粘液产生有关.
- SLC26A4有助于肺部疾病的发病,包括喘.
- 几种SLC26A4抑制剂在治疗各种疾病表型方面表现出潜力.
结论:
- SLC26A4是喘发展和进展的一个重要因素.
- SLC26A4 抑制剂为喘提供了一个有前途的治疗途径.
- 进一步的研究对于优化SLC26A4向性喘治疗至关重要.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
267
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
267
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
261
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
261
Antiasthma Drugs: β2-Adrenoceptor Agonists
243
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
243
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management
378
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
378
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K


